 The purpose of this study is to compare the treatment effect at week 26 between the two groups, sulfonylurea SU, glimepiride administration and thiazolidinedione TZD, Pioglitazone administration, as the third-order drug among patients whose treatment is not sufficient after the combined administration of Metformin and Alogliptin. 